Sun Pharma Acquires Innovcare Lifesciences in $28.7m Deal
Sun Pharmaceutical Industries has agreed to acquire India-based Innovcare Lifesciences for approximately Rs2.71bn ($28.7m) through a cash transaction, expected to close by 31 July 2026. The acquisition is part of Sun Pharma's strategy to expand its product portfolio and strengthen market presence.
Tickers: $MSD